A Comparison of Effects of Short-Term Steady State Low Dose Exposure of Extended Release (Advagraf) and Immediate Release (Prograf) Formulations of Tacrolimus on Renal Perfusion and Function in Healthy Male Volunteers

Trial Profile

A Comparison of Effects of Short-Term Steady State Low Dose Exposure of Extended Release (Advagraf) and Immediate Release (Prograf) Formulations of Tacrolimus on Renal Perfusion and Function in Healthy Male Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Nov 2012

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Coronary artery restenosis; Graft-versus-host disease; Lupus nephritis; Psoriasis; Rheumatoid arthritis; Transplant rejection; Ulcerative colitis
  • Focus Pharmacodynamics
  • Sponsors Astellas Pharma Canada
  • Most Recent Events

    • 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Sep 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top